liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations
Medical Products Agency, Uppsala, Sweden.
Karolinska University Hospital, Stockholm, Sweden.
Karolinska University Hospital, Stockholm, Sweden.
Uppsala University Hospital, Uppsala, Sweden.
Show others and affiliations
2007 (English)In: Medical Oncology, ISSN 1357-0560, E-ISSN 1559-131X, Vol. 24, no 3, 267-272 p.Article in journal (Refereed) Published
Abstract [en]

Due to concerns related to treatment with erythropoietin (EPO) and possible negative effects on tumour control, a workshop was organised by the Medical Products Agency of Sweden with the aim to revise national treatment guidelines if needed. In patients with solid tumours, conflicting results have been reported with respect to tumour control and survival. Until further notice it is therefore recommended that EPO should be used restrictively in the treatment of patients with cancer and that the anticipated improvement in quality of life should be evaluated against potential risks.

Place, publisher, year, edition, pages
Humana Press, 2007. Vol. 24, no 3, 267-272 p.
Keyword [en]
Erythropoietin Anemia Epoetin Cancer therapy Safety Erythropoietin receptor
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-101358DOI: 10.1007/s12032-007-0037-5PubMedID: 17873301OAI: diva2:666084
Available from: 2013-11-21 Created: 2013-11-21 Last updated: 2013-12-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Albertsson, Maria
In the same journal
Medical Oncology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 24 hits
ReferencesLink to record
Permanent link

Direct link